Haplogen Bioscience GmbH

https://www.haplogen.com

Haplogen GmbH is a privately held biotechnology company in Vienna, Austria, with active programs designed to combat viral infectious diseases. Haplogen employs an entirely novel genetics technology platform to identify novel host factors as candidate drug targets that block viral infection. This approach creates a higher barrier to the emergence of resistant virus strains, which is becoming a significant concern. Haplogen is building a pipeline of antiviral programs mainly in viral diseases that have no treatment option available. Despite improved hygiene and successful vaccination programs, infectious diseases remain a major cause of morbidity and mortality. Emerging resistance to conventional drugs and a lack of scientific tools further add to this immense medical and socioeconomic problem. Haplogen was founded in 2010 by the inventor of haploid genetic screens in human cell lines, Thijn Brummelkamp, together with scientists from CeMM, the Research Center for Molecular Medicine. *

	Start	2010-01-01 established
	Industry	cell line development (research assays)
	Industry 2	cell line/system (research assays)
	Person	Casari, Georg (CeMM 201211 Director + Haplogen 201211 CEO + founder before Oridis Biomed + Cellzome + Lion Bioscience)

	Region	Wien (Vienna)
	Country	Austria
	Street	7 Dr. Bohr-Gasse Campus Vienna Biocenter 5
	City	1030 Wien
	Tel	+43-1-916-5522-10
		Address record changed: 2020-12-02

Basic data	Employees	A: 1 to 10 (2013-10-17)

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)